Search for: "Par Pharmaceutical"
Results 101 - 120
of 303
Sorted by Relevance
|
Sort by Date
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
7 Oct 2009, 9:59 pm
Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing them of infringing Sanofi's patent covering Eloxatin ®, U.S. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories,… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
13 Sep 2013, 7:43 am
Coming in "third place" was Par Pharmaceuticals based in Woodcliff Lake, New Jersey. [read post]
23 Feb 2012, 4:11 pm
On October 14, 2011, Par Pharmaceutical, Inc. [read post]
20 Aug 2014, 7:08 am
" Par Pharmaceutical, Inc. et al v. [read post]
3 Aug 2015, 6:50 am
" Par Pharmaceutical, Inc. et al v. [read post]
21 Aug 2015, 11:16 am
Bloomberg reports on an unfavorable result for Takeda's drug Velcade .Link: http://www.bloomberg.com/news/articles/2015-08-20/takeda-velcade-patent-overturned-in-win-for-generic-drug-makersRecall the Federal Circuit has stated: A party must … meet a high standard in order to rely on inherency to establish the existence of a claim limitation in the prior art in an obviousness analysis—the limitation at issue necessarily must be present, or the natural result of the combination… [read post]
13 Mar 2013, 4:45 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
15 Jan 2013, 11:33 am
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
2 Dec 2009, 11:05 am
The $74.4 million U.S. market for generic dronabinol is also highly concentrated, with only Watson and Par Pharmaceuticals currently supplying the drug. [read post]
13 Jan 2018, 8:00 pm
Il peut être recherché à cet égard en responsabilité même par un demandeur à qui le générique a été prescrit. [read post]
3 Jun 2010, 2:23 pm
In 2003, pursuant to the Hatch-Waxman Act, two generic companies, Watson Pharmaceuticals and Paddock Laboratories (in partnership with Par Pharmaceuticals), each filed Abbreviated New Drug Applications ("ANDAs") with the FDA, seeking to market much cheaper, generic versions of AndroGel well before the expiration of Solvay's patent in 2020. [read post]
3 Nov 2014, 9:48 am
Background In a recent decision, JHP Pharmaceuticals LLC v. [read post]
3 Jan 2009, 7:04 am
Today when I compared my initial days with recent times, I feel that Indian Patent Examiners are inching at par with US and European counterparts. [read post]
22 Jun 2010, 9:00 am
This case inolves the alleged failure of Matrixx, a pharmaceutical company, to disclose that there was evidence that one of its cold products, Zicam Cold Remedy, caused anosmia, or the loss of smell. [read post]
6 Apr 2009, 11:19 am
The Challenges and Opportunities in India The challenge now is to develop biogenerics at par with chemical counterparts. [read post]
18 Feb 2021, 7:49 pm
Hikma Pharmaceuticals USA Inc. [read post]
